Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Yale researchers develop peptide that promotes new growth in laboratory animals with injured spinal cords

Yale University : 29 May, 2002  (New Product)
Yale researchers have developed a synthetic peptide that promotes new nerve fiber growth in the damaged spinal cords of laboratory rats and allows them to walk better, according to a study published Thursday in the journal Nature.
Yale researchers have developed a synthetic peptide that promotes new nerve fiber growth in the damaged spinal cords of laboratory rats and allows them to walk better, according to a study published Thursday in the journal Nature.

The finding could lead to the reversal of functional deficits resulting from brain and spinal cord injuries and caused by trauma and stroke, or brought about by degenerative diseases, such as multiple sclerosis.

The lead author of the study, Stephen Strittmatter, M.D., associate professor of neurology and neurobiology at Yale School of Medicine, said the study confirms which molecules block axon regeneration in the spinal cord and shows that a peptide can promote new growth. Axons are the telephone lines of the nervous system and carry a nerve impulse to a target cell.

'One of the prominent inhibitors is Nogo and we developed a way to block Nogo action with a peptide that binds to the Nogo receptor and prevents it from doing its normal job,' Strittmatter said. 'There is no drug used today to promote axon recovery in humans, so it is hard to predict how well this drug will work in humans.'

He said the laboratory rats were administered the peptide for four weeks through a catheter inserted into the spinal canal. A number of nerve fibers did grow back and the rats were able to walk better than without the treatment.

Before moving to human trials, Strittmatter said researchers first must determine whether the synethetic peptide can promote nerve fiber growth in animals weeks and months after injury and whether the compound is effective and safe for use in humans.

'There is some reason to think that the peptide might promote growth in older injuries because some damaged nerve fibers in the brain and spinal cord just sit there,' he said. 'If we had some way to block these inhibitors the nerve fibers might grow back again.'

The paper is the third that Strittmatter has published in Nature about this research. The first paper described the Nogo protein. The second paper detailed the receptor through which Nogo acts. This newest data demonstrates how to block the interaction and how to reverse its function pharmacologically.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo